JAZZ
Jazz Pharmaceuticals plc
NASDAQ · IEHealthcareBiotechnology
$243.47-1.64%
Price as of Jul 20, 2026
JAZZ valuation
Jazz Pharmaceuticals plc valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 10.19x
- P/E 2026E
- 10.26x
- P/E 2027E
- 9.64x
- P/E 2028E
- 9.28x
- P/S forward
- 3.36x
Trailing multiples
- P/E TTM
- 593.83x
- PEG TTM
- 0.10x
- Price / book
- 3.37x
- Price / sales
- 3.44x
- Price / cash flow
- 11.45x
Enterprise value
- Enterprise value
- $17.8B
- EV / sales
- 4.01x
- EV / EBITDA
- 32.75x
- EV / EBIT
- 36.06x
- Market cap
- $15.3B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.